FORM OF PROXY
2023-04-06
NOTICE OF ANNUAL GENERAL MEETING
2023-04-06
PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS, DECLARATION OF FINAL DIVIDEND, GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES, PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING
2023-04-06
Environmental, Social and Governance Report 2022
2023-04-06
Voluntary and Business Update Announcement Establishment of Joint Venture by Rxilient and Junshi Biosciences to Jointly Develop and Commercialize Toripalimab in Multiple Countries in Southeast Asia
2023-03-28
Voluntary and Business Update Announcement New Drug Application of Methotrexate Injection Approved in China
2023-03-27
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2022
2023-03-16
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022 AND PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION
2023-03-16
Notice of Board Meeting
2023-03-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
2023-03-01